Year-over-year earnings per share growth for the last twelve months: OPKO Health (OPK)

OPKO Health (OPK) - corporate logo

OPKO Health, Inc. (OPK) is a diversified player in the diagnostics and therapy of rare pathologies, leveraging the BioReference network. The quarterly EPS growth rate clearly demonstrates the market reaction to 10-Q reports, with the latest figure standing at -360.00. Business sustainability is driven by laboratory automation, while resilience to volatility is ensured by combining pharmacology with the optimization of biomaterial collection logistics.

OPKO Health (OPK) Year-over-year net earnings per share trend for the last twelve months: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for OPKO Health, Inc.

- market value and analyst target forecast:
Price Chart OPKO Health Corp.|OPK - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value OPKO Corp|OPK - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share OPKO Health|OPK - Net Asset Value|Market Value to Book Value Ratio opko.com|OPK - Company Total Assets
- company liabilities and liquidity data:
Debt to Equity OPKO Health, Inc.|OPK - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio OPKO Health|OPK - Aggregate Debt Obligations|Debts to Book Capitalization OPKO Health, Inc.|OPK - Company Long-Term Loans and Borrowings|Company Short-Term Debts OPKO Health|Quick Ratio opko.com
- earnings and market multiples details:
OPK - Net Profit|Expected Profit OPKO Health, Inc.|OPK - Price to Earnings Ratio|Projected Price to Earnings OPKO Corp|OPK - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple OPKO Health, Inc.|OPK - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months OPKO Health|OPK - Earnings per share for the trailing year|Quarterly EPS earnings growth opko.com|OPK - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year OPKO Health, Inc.
- issuer revenue and sales details:
OPK - Company Sales Volume|Projected Sales Volume OPKO Health Corp.|OPK - Market Cap to Revenue|Forward Price-to-Revenue Multiple OPKO Health Inc|OPK - Annual Revenue Growth (Last Twelve Months)
Summary company analytics:OPKO Corp - OPK
Manufactured product of opko.com

Investors must find a balance between operational risks and the efficiency of capital return. The business of OPKO Health, Inc. (OPK) relies on the profitability of BioReference laboratory diagnostics and the Rayaldee pharmaceutical segment. The GURU.Markets analytical system smooths reporting gaps via the quarterly EPS growth trend, converting earnings per share into a daily format. This metric measures net income dynamics, allowing for an assessment of the business's real scaling speed. The positive trend confirms the fundamental stability of the company.

Who OPKO Health, Inc. competes with

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months CDNA (caredx.com)|MRVI: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Cytek Biosciences, Inc.|Year-over-year earnings per share growth for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MDxHealth MDXH|LUCD: Year-over-year earnings per share growth for the last 12 months|PRE - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics Inc)|TRIB: Quarterly EPS earnings growth|prophaselabs.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HSCS (Heart Test Laboratories Inc.)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months